mitomycin has been researched along with Choroid Diseases in 7 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Choroid Diseases: Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in patients with primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG)." | 7.76 | Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study. ( Ollikainen, M; Puustjärvi, T; Rekonen, P; Teräsvirta, M; Uusitalo, H, 2010) |
" Before the surgery, his intraocular pressure (IOP) was 20 to 22 mm Hg with bimatoprost 0." | 3.85 | Bimatoprost-induced late-onset choroidal detachment after trabeculectomy: A case report and review of the literature. ( Kiuchi, Y; Nakakura, S; Noguchi, A; Tabuchi, H, 2017) |
"To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in patients with primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG)." | 3.76 | Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study. ( Ollikainen, M; Puustjärvi, T; Rekonen, P; Teräsvirta, M; Uusitalo, H, 2010) |
"Mitomycin C (MMC) used as an additive agent in glaucoma surgery has been shown to improve the postoperative results of intraocular pressure (IOP), but may also lead to higher incidences of postoperative wound healing disorders and of hypotonia with choroidal detachment." | 3.72 | [Clinical experiences and results of application of mitomycin C in trabeculectomy]. ( Hudde, T; Laube, T; Ritters, B; Selbach, M, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakakura, S | 1 |
Noguchi, A | 1 |
Tabuchi, H | 1 |
Kiuchi, Y | 1 |
Lee, E | 1 |
Doyle, E | 1 |
Jenkins, C | 1 |
Ollikainen, M | 1 |
Puustjärvi, T | 1 |
Rekonen, P | 1 |
Uusitalo, H | 1 |
Teräsvirta, M | 1 |
Laube, T | 1 |
Ritters, B | 1 |
Selbach, M | 1 |
Hudde, T | 1 |
Westfall, AC | 1 |
Ng, JD | 1 |
Samples, JR | 1 |
Weissman, JL | 1 |
Wang, J | 1 |
El-Saheb, H | 1 |
Lesk, MR | 1 |
7 other studies available for mitomycin and Choroid Diseases
Article | Year |
---|---|
Bimatoprost-induced late-onset choroidal detachment after trabeculectomy: A case report and review of the literature.
Topics: Aged; Antihypertensive Agents; Bimatoprost; Choroid Diseases; Glaucoma, Open-Angle; Humans; Intraocu | 2017 |
Trabeculectomy surgery augmented with intra-Tenon injection of mitomycin C.
Topics: Aged; Blister; Choroid Diseases; Cysts; Eye Diseases; Glaucoma; Humans; Hyphema; Injections; Intraoc | 2008 |
Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study.
Topics: Absorbable Implants; Aged; Anterior Chamber; Choroid Diseases; Collagen; Drug Implants; Exfoliation | 2010 |
[Clinical experiences and results of application of mitomycin C in trabeculectomy].
Topics: Aged; Choroid Diseases; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; Humans; Intr | 2003 |
Hypotonus maculopathy: magnetic resonance appearance.
Topics: Choroid Diseases; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Macula Lutea; Magnetic Resonan | 2004 |
Consultation section: cataract surgical problem.
Topics: Anisometropia; Anterior Chamber; Cataract; Choroid Diseases; Combined Modality Therapy; Female; Glau | 2007 |
Self-drainage of a posttrabeculectomy choroidal effusion: loss of protective effect.
Topics: Alkylating Agents; Choroid Diseases; Combined Modality Therapy; Exudates and Transudates; Glaucoma, | 2008 |